Helse ·
Longevity Care, Medicare Rules, and Cancer Drug
Kilder
- STAT: Hospitals’ next lucrative bet — longevity clinics
- Finance: Sarah Todd: Hospital Longevity Clinics Sell Time and Attention, Not Proven Medicine - BigGo Finance
- Beckershospitalreview: CMS proposes public scores for Medicare Advantage provider directories, flat-fee limits for PBMs
- Modernhealthcare: CMS issues provider directory, PBM transparency rule - Modern Healthcare
- STAT: STAT+: RevMed’s pancreatic cancer drug nears European approval
- Streamlinefeed: European Regulators Recommend Approval for Revolution Medicines' First-in-Class Pancreatic Cancer Drug - https://streamlinefeed.co.ke/
- STAT: Opinion: Is Milton Friedman to blame for America’s health care woes?
- STAT: Opinion: I thought I knew why patients stopped taking their medicine. I was wrong
- Beckershospitalreview: 3 health systems ending hospital-at-home programs
- Medicaldaily: Cone Health Ends Its Hospital at Home Program Even as Medicare Waiver Runs Through 2030, Raising Sustainability Questions - Medical Daily
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.